Submit a new Challenge for the 2018 CRACK IT competition
Posted on 11/01/2018
The “3Rs” – standing for Replacement, Reduction and Refinement – is a commonly used acronym used to describe a more humane approach to the type of research that would previously have involved animal experimentation.
The National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs) issues regular “CRACK-IT Challenges” with the aim of accelerating the availability of technologies which will deliver i) measurable 3Rs impacts, ii) new marketable products and iii) more efficient business processes.
NC3Rs is now inviting submissions from sponsors for new challenges for their 2018 CRACK IT competition.
Since 2011, CRACK IT has showcased 28 Challenges, invested almost £20 million and connected more than 200 organisations from industry and academia in 25 projects to develop innovative products to address bioscience needs.
Sponsor a CRACK IT Challenge
CRACK IT funds collaborations between industry, academics and SMEs to solve scientific challenges which deliver 3Rs and commercial benefits, either by improving business processes or developing a novel technology or approach. As Sponsor of a Challenge you will be able to provide early end user input and access new technologies that will have 3Rs impact and deliver scientific benefits to your business.
NC3Rs are inviting submissions from Sponsors for new Challenges which will benefit science, business and the 3Rs. Challenges can come from the industrial, academic or charitable sectors. Further information on the role of a Sponsor can be found here and information on the Challenges funded so far can be found here.
If you have an idea for a new CRACK IT Challenge for 2018:
– Complete and return the ‘Submit your Challenge’ form on the CRACK IT website; or
– Contact the CRACK IT team at email@example.com for further information.
The deadline for new Challenge submissions is 1 March 2018.
If you would like to discuss opportunities and support mechanisms for biotechnology innovations please contact a member of KTN’s Biotechnology Team.
If you enjoyed this news story, you might also like to read: